Tracy Humphries scite author profile

Recently, the Coalition Epidemic Preparedness Innovations (CEPI) announced their ambition to develop vaccines against emerging diseases in 100 days. mRNA vaccines are a manufacturing modality that is suited to meet the 100-day strategy. The technology offers great benefits and potential for infectious diseases and personalized medicines due to the advantages in flexibility, cost, and speed of development, but there are still challenges to overcome to fully realize the potential. How can manufacturers prepare for rapid response?

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Tracy Humphries

Contrasting Approaches to Natural Learning Environment Interventions

Characterizations of the competence of parents of young children with disabilities

Discovery to delivery in 100 days: RNA therapeutics & their role in future pandemic preparedness

Contact Info

Product

Resources

About